A61P 1/04

Sub-Class

Watch 2Status Updates

Stats

Description

Class  A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS


Subclass 1/04: Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Recent Patents

Patent #TitleFiling DateIssue DatePatent Owner
10537562 Delayed release pharmaceutical composition of pantoprazole and process for formulation thereofOct 06, 17Jan 21, 20Jubilant Generics Limited
10517928 Pharmaceutical composition for treating and/or preventing esophageal stenosisAug 06, 15Dec 31, 19Kagoshima University
10512635 Uses of benzimidazole derivative for nocturnal acid breakthroughJun 08, 16Dec 24, 19CJ HealthCare Corporation; RAQUALIA PHARMA INC.;
10513561 Anti-MYL9 antibodyJan 11, 17Dec 24, 19NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY; Eisai R & D Management Co., Ltd.;
10487053 Acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamineMar 17, 17Nov 26, 19DAEWOONG PHARMACEUTICAL CO., LTD
10463709 Short synthetic peptide for treating diseases and/or conditions related to angiogenesisApr 14, 16Nov 05, 19Mackay Memorial Hospital
10463710 Short synthetic peptide for the treatment and/or prophylaxis of autoimmune and inflammatory disordersApr 14, 16Nov 05, 19Mackay Memorial Hospital
10420843 Compositions and methods relating to salts of specialized pro-resolving mediatorsNov 28, 17Sep 24, 19Thetis Pharmaceuticals LLC
10414731 Substituted oxopyridine derivativesSep 22, 15Sep 17, 19Bayer Pharma Aktiengesellschaft
10399945 Tetrahydronaphthyl urea derivativeSep 21, 18Sep 03, 19MOCHIDA PHARMACEUTICAL CO. LTD
10383881 1,5-dihydro-2H-pyrrol-2-one compounds and methods of using sameDec 22, 17Aug 20, 19Frequency Therapeutics, Inc.
10314859 Use of gastrointestinally administered porous enteron sorbent polymers to prevent or treat radiation induced mucositis, esophagitis, enteritis, colitis, and gastrointestinal acute radiation syndromeFeb 02, 18Jun 11, 19CYTOSORBENTS CORPORATION
10308615 Heterocyclic compounds as inhibitors of Vanin-1 enzymeMay 16, 16Jun 04, 19Pfizer Inc.
10308655 Method of treating Crohn's disease comprising a TLR2 antagonistDec 23, 15Jun 04, 19AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
10251933 Proteins for the treatment of epithelial barrier function disordersApr 06, 18Apr 09, 19Second Genome, Inc.
10238697 Lactococcus lactis producing TSLP or IL-25 and their uses as probiotics and therapeuticsApr 12, 16Mar 26, 19Ares Trading SA
10195235 Methods for treating ulcerative colitisOct 24, 17Feb 05, 19CRESTOVO HOLDINGS LLC
10166204 Sphingosine kinase type 1 inhibitors and uses thereofApr 16, 18Jan 01, 19Enzo Therapeutics, Inc.
10144978 Probiotic bifidobacterium strainMay 10, 12Dec 04, 18ALIMENTARY HEALTH LTD.
10137162 L.Jan 26, 18Nov 27, 18King Saud University

more results

Recent Publications

Publication #TitleFiling DatePub DatePatent Owner
2019/0358,288 COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ENVIRONMENTAL ENTEROPATHYFeb 12, 18Nov 28, 19Not available
2019/0337,897 NOVEL TETRAHYDRONAPHTHYL UREA DERIVATIVEJul 17, 19Nov 07, 19MOCHIDA PHARMACEUTICAL CO. LTD
2019/0315,873 ANTI-MET ANTIBODIES AND USES THEREOFJun 23, 17Oct 17, 19Not available
2019/0314,402 ORAL COMPOSITIONS FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUXSep 18, 18Oct 17, 19ALFASIGMA S.P.A.
2019/0274,983 COMPOSITIONS COMPRISING DESAMINOTYROSINE AND USES THEREOF TO ENHANCE TYPE I INTERFERON STIMULATIONOct 26, 17Sep 12, 19Washington University
2019/0255,122 PREBIOTIC BACTERIOPHAGE CONTAINING COMPOSITION FOR TREATMENT OF GASTROINTESTINAL INFLAMMATIONSep 25, 18Aug 22, 19DEERLAND ENZYMES, INC.
2019/0177,433 METHOD OF TREATMENT OF GUT INFLAMMATORY DISEASES SUCH AS INFLAMMATORY BOWEL DISEASES (IBD) OR IRRITABLE BOWEL SYNDROME (IBS)Jun 16, 17Jun 13, 19Not available
2019/0152,971 Imidazo[1,2-A]Pyridine Derivatives, Methods for Preparing the Same and Use ThereofJul 04, 17May 23, 19Not available
2019/0125,665 Suckable and/or melt-in-mouth tablet based on hyaluronic acid and chondroitin sulphate and salts thereof for use in the treatment of subpopulation of GERD patientsJun 27, 18May 02, 19Not available
2019/0008,905 COMPOSITIONS FOR MANAGEMENT OF WOUNDS, SKIN DISEASES, DEHYDRATION, CHRONIC DISEASES, AND RESPIRATORY DISEASESJan 08, 18Jan 10, 19Not available
2018/0360,941 HELICOBACTER PYLORI VACCINESDec 14, 16Dec 20, 18Technische Universität München; MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSC HAFTEN E.V.;
2018/0134,749 NOVEL PEPTIDE AND COMPOSITION CONTAINING THE SAMEMay 25, 16May 17, 18Not available
2018/0118,756 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITYApr 14, 16May 03, 18Not available
2013/0177,646 Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic DisturbanceJan 23, 12Jul 11, 13MCNEIL AB
2013/0039,892 ADHERENT STROMAL CELLS DERIVED FROM PLANCENTAS OF MULTIPLE DONORS AND USES THEREOFApr 21, 11Feb 14, 13PLURISTEM LTD.
2013/0039,897 COMPOSITIONS AND METHODS FOR REGULATING NEUTROPHIL MOVEMENT AND NEUTROPHIL NUMBERS IN A BODY REGIONAug 10, 12Feb 14, 13THE TEXAS A&M UNIVERSITY SYSTEM
2013/0028,877 LACTOBACILLUS JOHNSONII La1 NCC533 (CNCM I-1225) AND IMMUNE DISORDERSMay 07, 10Jan 31, 13NESTEC S.A.
2012/0301,451 NON-FERMENTED COMPOSITIONS COMPRISING A CEREAL BASED FRACTION AND A PROBIOTIC AND USES THEREOFDec 22, 10Nov 29, 12Probi AB
2012/0269,787 SYSTEMIC, ALLOGENIC STEM CELL THERAPIES FOR TREATMENT OF DISEASES IN EQUINESJul 03, 12Oct 25, 12COOK GENERAL BIOTECHNOLOGY LLC
2012/0213,858 ANTI-REFLUX INFANT NUTRITIONApr 15, 10Aug 23, 12N.V. NUTRICIA

more results

Top Owners in This Subclass

Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More

Patents Issued To Date - By Filing Year

Average Time to Issuance